EUVIMEDEUVIMED entdecken
Crossref

Single-centre experience of using a new Lumen-apposing metal stent for approved and off-label indications

D. Paduano, F. Auriemma, F. Calabrese, C. Gentile, M. Spertino, C. Hassan, A. Repici, B. Mangiavillano

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S414-S415

DOI: 10.1055/s-0044-1783738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von D. Paduano und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Electrocautery-enhanced lumen-apposing metal stents (LAMS) they were originally developed to facilitate drainage of pancreatic fluid collections, later on, they got approved for gallbladder drainage (for non-surgical candidates) and bile duct drainage (in case of failed ERCP or malignant distal biliary obstruction). Lately, LAMS have also been used for off-label indications, including gastrojejunostomy and drainage of postsurgical collections. Our objective was to analyze the indications, technical/clinical success rates and complications of all LAMS inserted in the last 3 years at our center using a new device called Hot SPAXUS.

Methods

Data from 56 consecutive patients who had a LAMS (Hot SPAXUS-Taewoong Medical) placed were analyzed. Technical success was defined as the successful deployment of the LAMS to the desired location. Clinical success was defined as follows: for cholecystoduodenostomy, cholecystogastrostomy and choledochoduodenostomy:≥50% decline in baseline serum bilirubin within 2 weeks; for gastrojejunostomy: resolution of gastric outlet obstruction and successful resumption of oral intake; for cholecystitis: resolution of sepsis; for ileo-colonstomy: resolution of the obstructive picture without the need for surgical intervention; and finally for pyloric occlusion: transpyloric resolution of the obstruction Results In our center we have positioned 56 LAMS in as many patients for multiple indications. In particular, 26 cholecystogastrostomies were performed (46.4%) of which 57.7% for pancreatic cancer, 34.6% for cholecystitis, 3.9% for ampulloma and 3.9% for cholangiocarcinoma; 13 cholecystoduodenostomies (23.2%) of which 61.5% for cholecystitis and 38.5% for pancreatic cancer; 9 gastrojejunostomies (16.1%) of which 33.3% for pancreatic cancer, 22.2% for metastatic bladder cancer, 11.1% for gastric cancer, 11.1% for duodenal diverticulum, 11.1% for gallbladder cancer and 11.1% for gastrojejunal anastomosis cancer in a gastroresected patient; 5 choledochoduodenostomies (8.9%) of which 40% for ampullary tumor, 20% for pancreatic tumor, 20% for cholangiocarcinoma and 20% for metastatic bladder cancer; 2 transpyloric LAMS (3.6%) for benign pyloric stenosis; 1 Ileocolonstomy (1.8%) for cecal tumor infiltrating the ileocaecal valve. Overall technical and clinical success rates were high (55/56; 98.2% and 52/56; 92,6%, respectively).

Conclusions

LAMS are increasingly used tools in interventional EUS. Their use has proven effective and associated with high technical-clinical success rates with low complication rates. The number of off-label indications for LAMS is also growing, associated with high technical and clinical success rates, with acceptable complication rates. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Paduano, D., Auriemma, F., Calabrese, F., Gentile, C., Spertino, M., Hassan, C., Repici, A., & Mangiavillano, B. (2024). Single-centre experience of using a new Lumen-apposing metal stent for approved and off-label indications. Endoscopy, 56(S 02 S 02), S414-S415. https://doi.org/10.1055/s-0044-1783738

Vancouver

Paduano D, Auriemma F, Calabrese F, Gentile C, Spertino M, Hassan C, et al. Single-centre experience of using a new Lumen-apposing metal stent for approved and off-label indications. Endoscopy. 2024;56(S 02 S 02):S414-S415. doi:10.1055/s-0044-1783738

BibTeX
@article{Paduano2024,
  author = {Paduano, D. and Auriemma, F. and Calabrese, F. and Gentile, C. and Spertino, M. and Hassan, C. and Repici, A. and Mangiavillano, B.},
  title = {Single-centre experience of using a new Lumen-apposing metal stent for approved and off-label indications},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S414--S415},
  doi = {10.1055/s-0044-1783738}
}
Kostenlos starten →